MIRA INFORM REPORT

 

 

Report Date :

16th May, 2006

 

IDENTIFICATION DETAILS

 

Name :

MICROFILT INDIA PRIVATE LIMITED

 

 

Registered Office :

107, Vardhman Complex, L S B Marg, Vikhroli (West), Mumbai-400083, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2005

 

 

Date of Incorporation :

07.02.1994

 

 

CIN No.:

U74140MH1994PTC076445

 

 

Com. Reg. No.:

11-76445

 

 

TAN No.:

(Tax Deduction & Collection Account No.)

MUMM16896F

 

 

PAN No.:

(Permanent Account No.)

AAACM4267C

 

 

Legal Form :

A Private Limited Liability Company

 

 

Line of Business :

Trader of Cartridges/ Membrances/ Housings/ S S Fittings

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 11500

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established company having satisfactory track. Trade relations are fair. General financial position is satisfactory. Payments are usually correct and as per commitments. The company can be considered good for normal business dealings at usual trade terms and conditions

 

LOCATIONS

 

Registered Office/ Head Office/ Factory :

107, Vardhman Complex, L S B Marg, Vikhroli (West), Mumbai-400083, Maharashtra

Tel. No.:

91-22-25773021/2/3

Fax No.:

91-22-25787251

E-Mail :

innovations@microfiltindia.com

 

http://www.microfiltindia.com

 

 DIRECTORS

 

Name :

Mr. Magan L Khakharia

Designation :

Director

Address :

15, Jeevan, 125 Senapati Bapat Road, Matunga, Mumbai-400016, Maharashtra

Date of Birth/Age :

21.12.1963

Date of Appointment :

07.02.1994

 

 

Name :

Mr. Nilesh C Badani

Designation :

Director

Address :

23-24, Vora Apartment, Vallabhbaug Lane, Ghatkoper (East), Mumbai-400077, Maharashtra

Date of Appointment :

07.02.1994

 

 

Name :

Mr. Shoeb A. Kurawadwala

Designation :

Director

Address :

60 Jyoti Vidyalaya, CST Road, Santacruz (East), Mumbai-400098, Maharashtra

 

 

 

MAJOR SHAREHOLDERS

 

Names of Shareholders

No. of Shares

 

 

Khakharia Laxmidas Magan

9000

Badani Chimanlal Nilesh

4000

Kurawadwala Abbas Shoeb

3000

Khakarria Magan Bhavna

1000

Badani Nilesh Priti

2000

Badani Chimanlal Sanjay

3000

Badani Chimanlal Chandrika

1000

Kurawadwala Shoeb Sakina

3000

Kurawadwala Abbas Sarfraz

1000

Kurawadwala Abbas Shabir

1000

Kurawadwala Abbas Abbabali

1000

Kurawadwala Abbas Nussaina

1000

 

 

Total

30,000

 

BUSINESS DETAILS

 

Line of Business :

Cartridges/ Membrances/ Housings/ S S Fittings

 

 

 

GENERAL INFORMATION

 

Employees:

30

 

 

Bankers :

Canara Bank

 

 

Facilities :

Secured Loans:

 

 

 

 

 

From Canara Bank O/D A/c

(Secured against negative lien of industrial Gata, Personal Guarantee of Directors & hypothecation of stock)

1.852

1.959

 

 

 

From Maruti Countrywide Auto Financial Services Limited (Secured against hypothecation of motor car)

0.284

0.427

 

 

 

Total

2.137

2..386

 

 

 

Unsecured Loans:

 

 

 

 

 

From Director

0

0

From Members

0

0

From Inter Companies

0.001

0.001

 

 

 

Total

0.001

0.001

 

 

 

Auditors :

C D Mehta & Associates

Chartered Accountant

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

100,000

Equity Shares

Rs. 10 each

Rs. 1.000 millions

 

 

 

 

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

30,000

Equity Shares

Rs. 10 each

Rs. 0.300 millions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

 

SOURCES OF FUNDS

 

 

31.03.2005

31.03.2004

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

0.300

0.300

2] Reserves & Surplus

 

2.618

1.369

NETWORTH

 

2.918

1.969

LOAN FUNDS

 

 

 

1] Secured Loans

 

2.137

2.386

2] Unsecured Loans

 

0.001

0.001

TOTAL BORROWING

 

2.138

2.387

 

 

 

 

TOTAL

 

5.056

4.056

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

1.757

1.540

Capital work-in-progress

 

 

 

 

 

 

 

INVESTMENT

 

-

-

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 
Inventories
 

2.788

3.614

 
Sundry Debtors
 

6.398

3.871

 
Cash & Bank Balances
 

0.187

0.162

 
Loans & Advances
 

1.391

0.549

Total Current Assets
 

10.764

8.196

Less : CURRENT LIABILITIES & PROVISIONS
 

 

 

 
Current Liabilities
 

6.311

4.790

 
Provisions
 

1.153

0.889

Total Current Liabilities
 

7.464

5.679

Net Current Assets
 

3.298

2.517

 

 

 

 

MISCELLANEOUS EXPENSES

 

-

-

 

 

 

 

TOTAL

 

5.056

4.056

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

 

31.03.2005

31.03.2004

Sales Turnover [including other income]

 

32.517

26.273

 

 

 

 

Profit/(Loss) Before Tax

 

1.951

0.974

Provision for Taxation

 

0.703

0.382

Profit/(Loss) After Tax

 

1.248

0.592

 

 

 

 

Export Value

 

1.713

0.722

 

 

 

 

Import Value

 

4.665

3.957

 

 

 

 

Total Expenditure

 

40.143

31.544

 

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2005

31.03.2004

PAT / Total Income
(%)
 

3.84

2.23

 
 
 

 

 

Net Profit Margin

(PBT/Sales)

(%)

 

6.99

4.45

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

 

20.32

10.00

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

 

0.67

0.49

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

 

3.29

4.09

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

1.44

1.44

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

We delve deep into a customer’s needs seeking innovations...

Depth means everything for us at Microfilt. Delving deep into a customer’s needs opens our minds, stirs our thoughts and channels our efforts to find a gem of a solution for specific microfiltration needs.

Leaders are not born. They are made. At Microfilt, leadership is a process of continuous improvisation, innovation and perfection on-the-job"

 

 

 

 

Our Mission

·                     To redefine microfiltration technology by providing superior technical expertise and achieving high customer satisfaction.

·                     To consistently develop cost-effective customized filtration solutions that meet international standards.

·                     To become partners in our customer's growth by ensuring consistent and reliable technical support.

Vision

To scale new heights as leading solution-provider in Biotech, Pharmaceuticals, Fine chemicals, Food & Beverage industry.

Our Work Culture

·                     Service to customers - with devotion, accountability and quality assurance.

·                     Technical solutions - that's tailor made for specific needs yet in line with changing situations.

·                     Filtration Solutions - that are embodied by state-of-the-art equipment and backed by dependable service.

·                     People first - continuous learning through training and customer-centric attitude.

·                     Quality - an eye for perfection and adherence to strict quality assurance parameters.

 

Profile

·                     Established in 1990 by highly experienced technocrats.

·                     Led by Promoter - Director Magan Khakharia, who heads a well-knit team of professionals providing an array of customized solutions & services.

·                     Our core services include a spectrum of customized solutions in key filtration technologies - including depth filtration, surface filtration, edge filtration and tangential flow filtration.

·                     Today, with over a thousand successful installations, we have assumed leadership status in depth  filtration technology in India.

·                     Our clientele includes a prestigious list of industry players from Pharmaceutical, Biotech, Fine Chemicals & Winery sectors, among others.

 

Service & Support Systems

·                     Well-trained team of engineers working with customers and capable of conducting product trials at customer sites anywhere in the country.

·                     Complete on-site installation and operational support.

·                     Dedicated technical support team for consumables, upgradation, trouble-shooting and emergency services.

·                     Deep industry know-how, technical excellence and customer - focused approach have won us more than just customers.

·                     We represent CUNO - A 3M Company, world leader in filtration & separation for the last several years in India.

"Total Customer Focus equals Total Customer Satisfaction. Meeting customers' needs quickly, resourcefully and consistently - is our biggest strength"

 

 

Our Strengths

 

·                     Strategic support from world leaders CUNO - A 3M company for application and distribution.

·                     No. 1 position in Depth Filtration for the Pharmaceutical Industry.

·                     No. 1 position in microfiltration solutions for the winery sector.

·                     In-house system design unit equipped with latest CAD systems, technical library, etc.

·                     Well-equipped application laboratory for all types of process development and test capacity.

·                     All-round solutions & support - consultancy, systems design & development, installation to maintenance & trouble-shooting.

·                     High degree of customer loyalty and client base that spans across India, Singapore, Australia & China.

 

Case Study:

 

 

Time, Talent and Technique. Together they show us a way out of every challenge."

Time and again, we are approached by peculiar situations by clients who need an expert solution "this instant" and we willingly oblige. Our vast pool of industry experience, know-how, and close interaction with customers from virtually every industry that needs filtration has given us a unique edge in coming up with fast, practical and value-based solutions to customer problems.

·                     Case Study 1

·                     Case Study 2

·                     Case Study 3

·                     Case Study 4

Case Study 1

 

The Need

Replacement of distillation process for color removal by filtration system.

The Strategy

·                     After analyzing the application, it was found that the color was due to insoluble colored impurity.

·                     Trials were conducted, which successfully removed the color with two-stage filtration system and by adding carbon prior to filtration.

Customer Delight

The project involved a total transition from distillation to filtration process which helped the customer to establish a cost effective process. The distillation process was very slow involving high capital investment and in the wake of huge export orders, the client was looking for better, faster and more productive solution. Filtration served to speed up the time (two hours compared to eight hours with distillation) and productivity substantially increased which enabled them to export in time. The client thus not only saved time, but also a substantial amount of money and energy.

 

 

Case Study 2

The Need

To eliminate the problem of black particle in the final drug meant for export.

The Strategy

After analyzing the problem, we found that the black particle was due to fine carbon. We decided to trap fine carbon from the process API solution. Trials were conducted and the fine carbon was successfully removed using the principle of depth filtration and electrokinetic adsorption.

Customer Delight

The black particle contamination was holding up approvals for the drug and the client had an export order to meet. By eliminating the problem, the client eventually met the qualitative specification of his overseas customer and the drugs were exported. The client later established the standard not only for the drug in question, but for the entire line of drugs.

 

 

Case Study 3

 

The Need

To reduce filtration cost for IV fluid filtration.

The Strategy

After analyzing the application, we found that colloidal contamination from Dextrose was clogging the final sterile membrane filters. The high cost of sterile membrane filters thus added to the company's overheads. We devised a strategy to trap this colloidal contamination in a cost-effective way by using a combination of CUNO Zeta plus & Life assure media. Accordingly, trials were conducted and effects of various Zeta plus media on the membrane were studied. A suitable combination of Zeta plus grade and Life assure media helped reduce the cost of filtration to almost two-third of the original cost.

Customer Delight

The clients were happy when they could achieve cost-cutting with appropriate modification of the existing filtration system. The Zeta plus housing and other necessary hardware was incorporated into the filtration system, thus significantly lowering filtration cost (a major component in manufacturing costs) and enhancing the client's profits.

 

 

Case Study 4

 

The Need

To avoid spillages and loss of product in the manufacturing process for human vaccines.

The Strategy

The primary need here was to replace an open filtration system with a closed one, which would avoid the spillages. After analyzing the situation and successful trials conducted with Zeta plus media, we could trap the haze. A closed module system, designed to prevent loss of product and process the entire volume in desired time, was thus established.

Customer Delight

The client wanted a quick solution for the spillage issue. Within 48 hours and with adequate trials, we could convince him about the qualitative aspect of filtrate and also about the advantages of a closed filtration system. The client was not only benefited with the transition but could ensure it in a manner that was clean and also helped him meet regulatory requirements.

 

 

 

 

 

 

 

 

 

 

Testimonials:

 

"A challenge overcome, a project well done is a customer for life ... won"

Our clients come in all shapes and sizes. They hail from all parts of India, Asia and the world. No wonder, we are obsessed with keeping our energies flowing to meet their changing needs by coming up with innovative solutions.

Here's the list ...

Our client list includes prominent industry-players with whom we share a longstanding relationship that's built on Trust, Respect and Integrity:

 

·                     Alembic

·                     Wockhardt

·                     Biological E

·                     Serum Institute

·                     Intervet India

·                     B. V. Biologicals

·                     Dr. Reddy's Laboratories

·                     Ranbaxy

·                     Baxter

·                     Fresinius

·                     Cipla

·                     Lupin

·                     Colgate

·                     Sun

·                     Torrent

·                     Ipca

·                     Divi's Laboratories

·                     Orchid

·                     Matrix Laboratories

·                     Srini Pharmaceuticals

·                     Haffkine's Institute

·                     Indian Immunologicals Ltd

·                     Panacea Biotech

·                     Shasun

·                     Zydus Cadila

·                     Emcure Biotech

·                     Fermenta Biotech and many others

 

 

 

Earnings per share: Rs. 42.60 (2005)

                                Rs. 19.73 (2004)

 

 

 

Fixed Assets:

 

v      Industrial Gala

v      Lab. Equipments

v      Furniture & Fixtures

v      Computer

v      Telephone

v      Refrigerator

v      Vehicle

v      Air Conditioner

v      Projector

v      Office Equipment

v      Camera

v      Fax Machine

 

 

 

 

 

Contact Us:

 

Microfilt India Pvt. Ltd.

Address

23, Vardhaman Complex,
LBS Marg, Vikhroli (W),
Mumbai 400 083, INDIA

Tel

91-22-25773021 / 2 / 3

Fax

91-22-25787251

E-mail

innovations@microfiltindia.com

 

 

 

 

 

 

 

 

 

 

 

 


CMT REPORT [Corruption, Money laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                   None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                           None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                           None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]       Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.30

UK Pound

1

Rs.78.45

Euro

1

Rs.54.88

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)              Ownership background (20%)                   Payment record (10%)

Credit history (10%)                    Market trend (10%)                                  Operational size (10%)

 


 

RATING

STATUS

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions